19920205
 Regeneron's Fourth-Quarter Net Loss More Than Doubled to $2.1 Million   The Wall Street Journal,  Feb 6, 1992  Regeneron Pharmaceuticals Inc, which went public in 1991 with a $99 million initial offering, said its net loss for the fourth quarter more than doubled to $2.1 million from $993,000 the previous year. Its full-year loss widened 36% to $4.5 million from $3.3 million.   
